Live Breaking News & Updates on Curevac Fourth Quarter

Stay updated with breaking news from Curevac fourth quarter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript

Operator: Greetings and welcome to the CureVac Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. ....

Roy Buchanan , Bevan Wang , Thaminda Ramanayake , Marcus Dalton , Alexander Zehnder , Mani Foroohar , Jim Cramer , Pierre Kemula , Sarah Fakih , Myriam Mendila , Exchange Commission , Anderson Cancer Center , German Federal Court , Sanofi Biomarin Pharmaceuticals , Corporate Communications , German Federal Patent Court , University Of Texas , Call Transcript April , Curevac Fourth Quarter , Full Year , Business Update Conference , Vice President , Investor Relations , Chief Executive Officer , Chief Development Officer , Chief Financial Officer ,

CureVac NV (CVAC) CEO Franz-Werner Haas on Q4 2021 Results - Earnings Call Transcript

CureVac NV (NASDAQ:NASDAQ:CVAC) Q4 2021 Earnings Conference Call April 28, 2022, 09:00 ET Company Participants Sarah Fakih - VP Corporate Communications & IR Franz-Werner Haas - CEO. ....

United States , Douglas Buchanan , Zhiqiang Shu , Roy Buchanan , Franz Werner Haas , Pierre Kemula , Markus Backman , Eun Yang , Klaus Edvardsen , Sarah Fakih , Company Participants , German Federal Ministry Of Education , European Commission , Boehringer Ingelheim , Exchange Commission , Vp Corporate Communications , German Federal Ministry Of Health , Corporate Communications , Conference Call April , Werner Haas , Curevac Fourth Quarter , Full Year , Business Update Conference , Vice President , Investor Relations , Chief Executive Officer ,